Global Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2026 ,inter alia, to consider and approve Unaudited Financial Results for ....
MEDANTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Global Health Ltd (Medanta) has informed BSE that its Board of Directors will meet on February 4, 2026, to consider and approve the unaudited financial results for the third quarter and nine months ended December 31, 2025. This is a routine SEBI Regulation 29 intimation disclosing the upcoming board meeting date. The company's trading window for insiders is already closed since January 1, 2026 and will reopen 48 hours after the results are declared. The actual financial numbers will be disclosed after the board meeting concludes.
No direct impact on stock price from this filing as it only confirms an upcoming results date. Investors should watch for the Q3 FY26 results announcement post-February 4, which could move the stock based on actual revenue, profit, and margin performance.